Amdocs Stock Price, News & Analysis (NASDAQ:DOX)

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs declared a quarterly dividend on Wednesday, August 7th. Stockholders of record on Monday, September 30th will be paid a dividend of $0.285 per share on Friday, October 25th. This represents a $1.14 dividend on an annualized basis and a dividend yield of 1.73%. The ex-dividend date of this dividend is Friday, September 27th. View Amdocs' Dividend History.

Amdocs announced that its board has approved a share buyback program on Thursday, November 9th 2017, which allows the company to repurchase $800,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its shares are undervalued.

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings data on Wednesday, August, 7th. The technology company reported $1.19 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.11 by $0.08. The technology company earned $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Amdocs had a net margin of 9.90% and a return on equity of 15.70%. The firm's revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period in the prior year, the business posted $1.03 EPS. View Amdocs' Earnings History.

Amdocs is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for Amdocs.

Amdocs issued an update on its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of $4.28-4.34 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.28. The company issued revenue guidance of $4.070233088-4.109981458 billion, compared to the consensus revenue estimate of $4.09 billion.

1 brokers have issued 1-year target prices for Amdocs' shares. Their forecasts range from $75.00 to $75.00. On average, they expect Amdocs' stock price to reach $75.00 in the next twelve months. This suggests a possible upside of 14.0% from the stock's current price. View Analyst Price Targets for Amdocs.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Amdocs.

News coverage about DOX stock has been trending negative this week, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Amdocs earned a news impact score of -2.9 on InfoTrie's scale. They also assigned press coverage about the technology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Amdocs.

Some companies that are related to Amdocs include Cognizant Technology Solutions (CTSH), Verisign (VRSN), Wipro (WIT), NTT DATA CORP/ADR (NTDTY), Obic (OBIIF), EPAM Systems (EPAM), Aspen Technology (AZPN), Zscaler (ZS), GEMALTO NV/S (GTOMY), PROS (PRO), Endava (DAVA), Sogou (SOGO), Perficient (PRFT), Virtusa (VRTU) and Formula Systems (1985) (FORTY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include QUALCOMM (QCOM), Micron Technology (MU), Applied Materials (AMAT), Activision Blizzard (ATVI), Intel (INTC), Starbucks (SBUX), Delta Air Lines (DAL), Home Depot (hd), Oracle (ORCL) and Target (TGT).

Amdocs' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Janus Henderson Group PLC (5.53%), Janus Henderson Group PLC (5.53%), Wells Fargo & Company MN (4.60%), BlackRock Inc. (3.03%), BlackRock Inc. (3.03%) and Invesco Ltd. (2.51%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, First Trust Advisors LP, Renaissance Technologies LLC, Clal Insurance Enterprises Holdings Ltd, Royal Bank of Canada, TimesSquare Capital Management LLC, Bank of Montreal Can and D. E. Shaw & Co. Inc..

DOX stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Nuveen Asset Management LLC, LSV Asset Management, Bank of America Corp DE, Wells Fargo & Company MN, BlackRock Inc., BlackRock Inc. and Bogle Investment Management L P DE.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $65.78.

Amdocs has a market capitalization of $9.18 billion and generates $3.97 billion in revenue each year. The technology company earns $354.39 million in net income (profit) each year or $3.74 on an earnings per share basis. Amdocs employs 24,381 workers across the globe.View Additional Information About Amdocs.

The official website for Amdocs is http://www.amdocs.com/.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]